ABUS - Arbutus Biopharma Corp
4.29
-0.160 -3.730%
Share volume: 1,383,401
Last Updated: 03-27-2026
Pharmaceutical Products/Pharmaceutical Preparations:
3.18%
PREVIOUS CLOSE
CHG
CHG%
$4.45
-0.16
-0.04%
View ratios
| Fiscal Date | 03-31-2024 | 06-30-2024 | 09-30-2024 | 12-31-2024 | 03-31-2025 | 06-30-2025 | 09-30-2025 | 12-31-2025 | |
|---|---|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | |
| Report Date | 05-02-2024 | 08-08-2024 | 11-06-2024 | 03-27-2025 | 05-14-2025 | 08-06-2025 | 11-13-2025 | 03-23-2026 | |
| Cash flow financing | 24.430 M | 24.370 M | 1.775 M | 1.421 M | 2.784 M | 453.000 K | 844.000 K | 1.640 M | |
| Other financing cash flows | 2.454 M | 2.011 M | 1.590 M | 1.422 M | 2.653 M | 453.000 K | 794.000 K | 1.640 M | |
| Cash flow | 16.829 M | 19.695 M | -30.947 M | 4.517 M | 742.000 K | 315.000 K | -14.992 M | -4.401 M | |
| Net income | -17.875 M | -19.796 M | -19.717 M | -12.532 M | -24.526 M | 2.523 M | -7.742 M | -3.756 M | |
| Depreciation | 355.000 K | 356.000 K | 336.000 K | 333.000 K | 330.000 K | 11.000 K | 11.000 K | 11.000 K | |
| Changes in inventories | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Changes in receivables | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Investing Cashflow | 11.694 M | 9.829 M | -11.986 M | 13.411 M | 11.349 M | 15.611 M | -10.019 M | -1.361 M | |
| Net Borrowings | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Investing Activity Other | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Dividends Paid | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Exchange Rate Effect | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Capital Expenditures | 95.000 K | 1.000 K | 0.000 | 86.000 K | 0.000 | 0.000 | 0.000 | -355.000 K | |
| Cash Change | 16.816 M | 19.687 M | -30.942 M | 4.484 M | 746.000 K | 336.000 K | -15.004 M | -4.400 M |